Provider
hybrid Cash pay onlyPallas Health: what it costs and how it works
Pallas Health sells both. A compounded semaglutide plan starts at $139 for the first month, and the FDA-approved branded products are available at cash-pay rates, with Wegovy listed at $1,349 a month.
The pricing and the detail
It is a technology platform operated by Brentmoor, Inc. rather than a medical practice, and the prescribing is done by Lion MD. Pallas names six dispensing pharmacies and two supervising clinicians, and both of those clinicians hold an active license in the federal NPI registry.
- Medication from
- $139
- Audit complete
- 4/5 checks
- Evidence attached
- 5 cited sources
Referral link. Opens in a new tab.
See Pallas Health pricing (opens in a new tab, we are paid a referral fee)We earn a referral fee if you start with Pallas Health. It never changes our audit. How we make money
Is Pallas Health legitimate? What we checked
Checked September 6, 2026
- Dispensing pharmacy
- 503A
- LegitScript certified
- Yes
- Price shown before intake
- Yes
- Cancel online
- none published
- Prescriber disclosed
- Yes
- Pharmacy named
- Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub, Foothills
Pallas told us by email on 6 September 2026 that cancelling is self-serve in the patient portal billing page, with no call or email needed and a pause option beside it. Their own pages do not say so, so we could not verify it, and they told us they intend to publish it.
What it costs
Medication, per month
$139 to $1,349
- Semaglutide Compounded, billed every 12 weeks after the first month
- $199 /mo
- Tirzepatide Compounded, billed every 12 weeks after the first month
- $299 /mo
Medication and care together. Nothing is billed to insurance, and the branded products are sold at pharmacy cash-pay rates
Key facts
- Dispensing pharmacies, named
- Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills
- Supervising clinicians, named
- Ana Lisa Carr MD and Kelly Tenbrink MD, both active in the federal NPI registry
- Branded product
- Wegovy, Zepbound, Ozempic and Mounjaro, at pharmacy cash-pay rates
- Video visit required
- In seven states and Washington DC. Elsewhere the intake is reviewed asynchronously
Sources
Every claim above is checked against the primary text, and the date is the day we last opened it.
-
1
Clinical disclosures
Pallas Health Primary text read and checked Checked September 6, 2026
-
2
Wegovy, cash-pay through Pallas Health
Pallas Health Primary text read and checked Checked September 6, 2026
-
3
NPI 1689841744, NPPES registry record
Centers for Medicare & Medicaid Services Primary text read and checked Checked September 7, 2026
-
4
NPI 1346482684, NPPES registry record
Centers for Medicare & Medicaid Services Primary text read and checked Checked September 7, 2026
-
5
GLP-1 treatment plans and prices
Pallas Health Primary text read and checked Checked September 6, 2026